Amino acid supplement
L-Tyrosine
L-Tyrosine after one dose: 50% at ~2.5 h, 25% at 5 h, 12.5% at 7.5 h.
Drawn from the half-life in the app's model, ~2.5 h. The model's figures
- Compound
- L-Tyrosine
- Symbol
- TYR
- Family
- Supplements
- Parts
- 13
- References
- 16
- Checked
- Last reviewed . Sources are listed below.
Overview
Sources in this part
L-tyrosine is an amino acid that van de Rest and colleagues (Nutrients, 2017) call "one of the conditionally essential amino acids", found in protein-rich foods such as dairy, meat, fish, eggs, seeds, nuts and beans.2 Hase and colleagues, in Pharmacology Biochemistry and Behavior in 2015, published a systematic review of the effects of tyrosine on behavior and cognition in healthy adults.1
The research on it as a supplement is mostly short trials of a single oral load given before a stress, a cognitive task or exercise.1 Jongkees and colleagues (Journal of Psychiatric Research, 2015) write that "reports on the effectiveness of TYR supplementation vary considerably, with some studies finding beneficial effects, whereas others do not".3 The same review concludes that "TYR is an effective enhancer of cognition, but only when neurotransmitter function is intact and DA and/or NE is temporarily depleted".3
The app grades the evidence for L-tyrosine as moderate; that is the app's own grade, and the trials below range from 8 to 80 participants where a number is stated, with mixed and sometimes null results.
How it works
Tyrosine is the precursor to dopamine and norepinephrine; Hase and colleagues write that the buffering effects of tyrosine on cognition "may be explained by tyrosine's ability to neutralize depleted brain catecholamine levels", and Jongkees and colleagues conclude it enhances cognition "only when neurotransmitter function is intact and DA and/or NE is temporarily depleted".1,3 Donnan and colleagues (PLOS ONE, 2025) state that "oral tyrosine supplementation can increase the ratio of tyrosine to other large neutral amino acids", which favours transport across the blood-brain barrier.4 Tumilty and colleagues (Medicine and Science in Sports and Exercise, 2020) measured the plasma ratio of tyrosine to competing amino acids and describe it as "a key determinant of brain tyrosine influx".5 In their discussion, van de Rest and colleagues speculate that extra precursor given to a system with already high dopamine synthesis capacity "may result in its inhibition", in older adults who showed larger plasma rises.2 That is a stated hypothesis, not a measured result, and the trial had no placebo group.2
Half-life and pharmacokinetics
Values from the Milligram app's model.
- Half-life
- ~2.5 h
- Bioavailability
- 90%
- Typical dose
- 500–2000 mg/dose
- Route
- Oral
- Time to peak
- ~1.5 h
Sources in this part
The app lists a half-life of about 2.5 hours, a bioavailability of 90% and a time to peak of about 1.5 hours. The sources report plasma tyrosine after large single loads, not an elimination half-life or an absolute bioavailability.
| Parameter | App's figure | Reported in the sources |
|---|---|---|
| Half-life | ~2.5 h | No elimination half-life was identified. In 17 older adults given 100, 150 or 200 mg/kg, plasma tyrosine "decreased from 2.5 h after ingestion, not returning to baseline levels within four hours"; this is a time after the dose, not a half-life.2 |
| Bioavailability | 90% | No figure was identified in the records returned by the queries run. |
| Time to peak | ~1.5 h | Approximately two hours in young adults after 100 and 150 mg/kg, as van de Rest and colleagues cite earlier work; in their own older adults, plasma levels "peaked at 90 min after the 100 mg/kg and 150 mg/kg body weight dose, but at 120 min after the 200 mg/kg dose", with the first sample taken at 90 min.2 Donnan and colleagues likewise write that tyrosine concentration "has been shown to peak two hours after single-dose" supplementation of 150 mg/kg.4 |
| Plasma response to dose | Not an app figure | In older adults the plasma rise was dose-dependent and "higher than for young adults with the same dose".2 Coull and colleagues (2016) reported that a single 150 mg/kg dose "was equally efficient at elevating serum TYR concentration relative to a double dose".6 |
The source figures for time to peak differ from the app's 1.5 hours in the young-adult estimate of about two hours; the older-adult samples began at 90 minutes, so an earlier peak cannot be excluded from that trial.2
Human studies
Most of the trials below gave tyrosine in a single test session, with 8 to 80 participants where a number is stated; Hase and colleagues report the same for all but one of the 15 studies they reviewed.1
| Study and year | Design | People | Dose and length | Main result |
|---|---|---|---|---|
| Deijen and Orlebeke, Brain Research Bulletin 19947 | Randomised crossover, tyrosine against placebo, 90 dB noise stressor | 16 healthy young subjects | 100 mg/kg tyrosine on one test day, placebo on the other | Better performance on two stress-sensitive cognitive tasks about 1 h after the dose; diastolic blood pressure lower at 15 min and equal to placebo at 1 h; no effect on mood, systolic blood pressure or heart rate |
| Deijen and colleagues, Brain Research Bulletin 19998 | Randomised, tyrosine-rich drink against calorie-matched carbohydrate-rich drink, during a combat course | 21 cadets (10 and 11) | Five daily doses of a protein-rich drink containing 2 g tyrosine; assessed before and on day 6 | Better memory and tracking task performance; lower systolic blood pressure; no effect on mood |
| Neri and colleagues, Aviation, Space, and Environmental Medicine 19959 | Double-blind, tyrosine against cornstarch placebo, one night of sleep loss | Number not stated in the PubMed record | 150 mg/kg in a split dose, 6 h into about 13 h of testing | Less decline on a psychomotor task and fewer vigilance lapses; improvements lasted on the order of 3 h |
| Waters and colleagues, Nutritional Neuroscience 200310 | Double-blind randomised, tyrosine against caffeine, phentermine, D-amphetamine and placebo, 40.5 h without sleep | 76 healthy males aged 18-35 | Tyrosine 150 mg/kg after 36 h without sleep; four-day protocol | No significant effect on any sleep parameter; prolactin release stimulated |
| Magill and colleagues, Nutritional Neuroscience 200311 | Same drug comparison, cognitive and motor tests after overnight sleep deprivation | Healthy young men (number not stated in the PubMed record) | Tyrosine 150 mg/kg at 15.30 h | Improved performance on several tests, less than D-amphetamine |
| McAllister and colleagues, Stress 202412 | Randomised against placebo before a mental stress challenge | 80 adults aged 21 ± 2.6 years (tyrosine n = 28, theanine n = 25, placebo n = 27) | L-tyrosine 2000 mg, single dose | Markers of stress not affected (the challenge raised salivary alpha-amylase, secretory immunoglobulin A, heart rate and state anxiety); fewer missed Stroop responses than placebo |
| Coull and colleagues, Medicine and Science in Sports and Exercise 20166 | Study 1 dose comparison; study 2 double-blind crossover, load carriage at 40 °C | 21 participants (study 1); 8 participants (study 2) | Study 1: two doses of 75 or 150 mg/kg against a sugar-free drink; study 2: tyrosine against placebo, dose not stated in the PubMed record | Study 1: single 150 mg/kg as efficient as a double dose at raising serum tyrosine; study 2: no change in cognitive decrements or time trial (19.78 ± 3.44 against 20.29 ± 3.55 min, P = 0.74) |
| Tumilty and colleagues, Medicine and Science in Sports and Exercise 20205 | Double-blind crossover, four trials 7 days apart, cycling then time trial at 30 °C | 8 recreationally trained men aged 23 ± 4 years | 0, 150, 300 or 400 mg/kg body mass before exercise | No difference in time trial performance (P = 0.579), core or skin temperature, heart rate, RPE or thermal sensation |
| Donnan and colleagues, PLOS ONE 20254 | Double-blind crossover against placebo, 92-minute intermittent cycling sprints at 32 °C | 8 trained male soccer players | 150 mg/kg one hour before exercise, 7 days apart | No difference in peak power (715 ± 98 against 724 ± 98 W), decision-making, appraisal or affect; plasma metanephrine lower at half-time with tyrosine |
| van de Rest and colleagues, Nutrients 20172 | Double-blind randomised crossover, no placebo arm, dose comparison | 17 adults aged 60-75, and 17 aged 18-35 as a comparison | Single 100, 150 or 200 mg/kg (older adults); 150 mg/kg (young adults) | Dose-dependent plasma rise, larger than in young adults; lower 3-back accuracy at higher doses |
Sources in this part
Reviews and pooled analyses
Hase and colleagues reviewed 15 studies and report that "tyrosine loading acutely counteracts decrements in working memory and information processing that are induced by demanding situational conditions such as extreme weather or cognitive load", while in most behavioural studies there were no significant effects on exercise performance.1 Attipoe and colleagues (Military Medicine, 2015), a rapid evidence assessment of 10 randomised and 4 controlled clinical trials searched to October 2012, made "a weak recommendation in favor of tyrosine" for cognitive stress "as all studies showed a positive effect".14 For physical performance under stressful physical conditions, the same assessment states that no recommendation could be made.14 The same authors conclude that "the available evidence is insufficient to make confident recommendations on the effectiveness of tyrosine for mitigating stress effects on physical/cognitive performance".14 Solon-Júnior and colleagues (Journal of Sports Sciences, 2023) pooled 10 interventions from 8 studies and report no significant differences between tyrosine and placebo for time to exhaustion (SMD = 0.02; p = 0.94) or time trial performance (SMD = -0.04; p = 0.85), with GRADE evidence rated moderate.15
Deeper analysis: Deijen and colleagues, stress and a combat course
Deijen and Orlebeke (Vrije Universiteit Amsterdam, Brain Research Bulletin, 1994) tested 16 healthy young subjects on two days, one after 100 mg/kg tyrosine and one after placebo, in random order, while a 90 dB noise stressor ran.7 Tyrosine improved two cognitive tasks done 1 h after the dose, lowered diastolic blood pressure at 15 min, and left mood, systolic pressure and heart rate unchanged.7 Deijen and colleagues (Brain Research Bulletin, 1999) gave 10 cadets five daily doses of a protein-rich drink containing 2 g tyrosine and 11 cadets a carbohydrate-rich drink with the same calories (255 kcal) during a combat training course.8 The tyrosine group performed better on a memory task and a tracking task, and systolic blood pressure was lower; mood showed no effect, and the measure of the norepinephrine metabolite MHPG is named in the record without a result.8 The PubMed records for both trials give no funding statement, limitations section or author tie to a supplier.
Deeper analysis: sleep-loss trials (Neri; Waters; Magill)
Neri and colleagues (Naval Aerospace Medical Research Laboratory, 1995) had subjects do about 13 h of nighttime work after sleep loss; one half received 150 mg/kg tyrosine in a split dose 6 h in, the other half cornstarch placebo, double-blind.9 Tyrosine was associated with less decline on a psychomotor task and fewer lapses on a vigilance task, lasting on the order of 3 h; the authors suggest it "is a relatively benign treatment at this dose" and call for testing other doses and timings.9 Its PubMed record is labelled "Research Support, U.S. Gov't, Non-P.H.S." and states no participant number or conflict statement.9 Waters and colleagues (Pennington Biomedical Research Center, Nutritional Neuroscience, 2003) randomised 76 healthy males to tyrosine 150 mg/kg, caffeine 300 mg/70 kg, phentermine 37.5 mg, D-amphetamine 20 mg or placebo after 36 h without sleep.10 In recovery sleep, tyrosine "had no significant effect on any parameter of sleep" and no effect on any sleep-related measure against placebo, but it did stimulate prolactin release; D-amphetamine caused deleterious effects on many aspects of recovery sleep and phentermine impaired REM recovery sleep.10 Magill and colleagues (Nutritional Neuroscience, 2003), from the same group, report that improvements after medication were seen in running memory, logical reasoning, mathematical processing, tracking and visual vigilance, and that "although less effective than D-amphetamine, tyrosine improved performance on several tests".11 The authors write that tyrosine "may deserve further testing"; both PubMed records carry the label "Research Support, U.S. Gov't, Non-P.H.S." and neither gives a limitations statement or author ties.11,10
Deeper analysis: McAllister and colleagues, mental stress challenge
McAllister and colleagues (Texas State University, Stress, 2024) randomly assigned 80 subjects to L-tyrosine 2000 mg (n = 28), L-theanine 200 mg (n = 25) or placebo (n = 27) before a mental stress challenge of a Stroop task, mental arithmetic and a virtual reality active shooter drill.12 The challenge raised salivary alpha-amylase, secretory immunoglobulin A, heart rate and state anxiety; tyrosine and theanine "did not impact markers of stress", but tyrosine was associated with significantly fewer missed Stroop responses than placebo.12 The registry entry gives Texas State University as the investigator's affiliation, lists the tyrosine arm as 2000 mg given 40 minutes before the task, and names caffeine, theanine and tyrosine as the supplements examined, whereas the journal record reports tyrosine, theanine and placebo groups totalling 80.13,12 The PubMed record is labelled "Research Support, U.S. Gov't, Non-P.H.S."; no funder name, limitations or author ties are given in it, and the registry entry lists no posted results.12,13 The registry entry names Texas State University as lead sponsor, gives Hard Eight Nutrition, LLC (Bulk Supplements) as the source of the 2000 mg tyrosine powder, and lists an enrollment count of 109 against 80 subjects in the journal record.13,12
Deeper analysis: van de Rest and colleagues, dose and plasma response in older adults
van de Rest and colleagues (Wageningen University and Radboud University, Nutrients, 2017) ran a double-blind, randomised crossover trial in which 17 adults aged 60-75 each received single doses of 100, 150 and 200 mg/kg at least a week apart, with 17 adults aged 18-35 given 150 mg/kg as a comparison.2 The trial's N-back table gives n = 17 at 100 mg/kg, n = 16 at 150 mg/kg and n = 17 at 200 mg/kg in the older adults.2 The primary outcome was plasma tyrosine, and working memory (N-back task at 90 min) was a secondary aim.2 Plasma tyrosine rose with dose and was higher than in young adults at the same dose.2 Accuracy on the hardest, 3-back, load was 75.2, 68.1 and 66.6% hits (mean) at 100, 150 and 200 mg/kg in older adults, with "no main effect of dose" on the 0-, 1- and 2-back loads and none on false alarms or reaction times.2 The overall dose by load effect had p = 0.048, and the link to larger plasma rises had p = 0.035.2 The authors state "Tyrosine administrations were well tolerated; no adverse events were reported".2 Their stated limitation is that "we did not have a placebo-controlled design", so they cannot say whether tyrosine improved or diminished working memory against baseline; they call for placebo-controlled work including doses below 100 mg/kg.2 The study was funded by the European Fund for Regional Development and the Dutch provinces Gelderland and Overijssel; the funder "had no role in the design or implementation of the study", and the authors declare no conflicts of interest.2
Deeper analysis: exercise and heat trials (Coull; Tumilty; Donnan)
Coull and colleagues (University of Bedfordshire, 2016) first compared serum tyrosine after two 150 mg/kg doses, two 75 mg/kg doses and a sugar-free drink in 21 participants, then tested 8 participants on a load-carriage protocol at 40 °C.6 Exercise heat stress impaired some aspects of cognition, and tyrosine "did not alleviate these decrements"; the authors write "despite marked elevations in serum TYR concentration, ingestion of TYR did not influence cognitive function or physical performance during exercise heat stress".6 Tumilty and colleagues (Aberystwyth University, 2020) tested 0, 150, 300 and 400 mg/kg body mass in 8 men; the plasma ratio rose 5.3-, 7.7- and 8.2-fold while time trial performance and thermal and perceptual measures did not differ.5 Donnan and colleagues (PLOS ONE, 2025) ran 8 trained male soccer players through two 92-minute cycling sprint trials at 32 °C, 150 mg/kg against placebo, and found no difference in peak power, decision-making (86.9 ± 10.7% against 88.6 ± 7.0%), cognitive appraisal or affective states.4 Plasma metanephrine was higher at half-time on placebo than on tyrosine, but not before or after the protocol.4 The authors list as limitations that "there was no formal assessment of the effectiveness of the blinding of participants", that placebo effects cannot be excluded, and that the physiological stress response to the heat could have been more noticeable during running-based activity; in their methods they state that testing "had to be terminated early" because of the pandemic, with a minimum target sample of 8 recruited.4 Donnan and colleagues report no specific funding and no competing interests; the funding and ties in the Coull and Tumilty PubMed records are not stated.4,6,5
Doses reported in studies and on labels
Most trials give doses per kilogram of body mass, whereas the app states its typical dose of 500–2000 mg as an amount per dose; McAllister and colleagues, who gave a fixed 2000 mg, and Deijen and colleagues (1999), whose drink contained 2 g tyrosine per dose, are the trials here with a fixed amount matching the top of the app's range.12,8
| Source | Dose and route | Setting, comparator and n | Reference |
|---|---|---|---|
| Deijen and Orlebeke 1994 | 100 mg/kg, oral (ingestion), single | Against placebo, 90 dB noise, 16 subjects | 7 |
| Deijen and colleagues 1999 | 2 g tyrosine in a protein-rich drink, five daily doses | Against a carbohydrate-rich drink, 21 cadets | 8 |
| Neri and colleagues 1995 | 150 mg/kg in a split dose | Against cornstarch placebo, sleep loss, number not stated | 9 |
| Waters and colleagues 2003 | 150 mg/kg | After 36 h without sleep, against placebo and three active drugs, 76 males | 10 |
| Magill and colleagues 2003 | 150 mg/kg at 15.30 h | After overnight sleep deprivation, same comparators | 11 |
| McAllister and colleagues 2024 | 2000 mg, oral drink, single, 40 minutes before the task per the registry | Against placebo, 28 on tyrosine of 80 | 12,13 |
| Coull and colleagues 2016, study 1 | Two doses of 75 or 150 mg/kg (0900 and 1300 h) | Against a sugar-free drink, 21 participants | 6 |
| Tumilty and colleagues 2020 | 150, 300 or 400 mg/kg body mass in two 300 mL drinks | Against 0 mg/kg, 8 men, 7 days apart | 5 |
| Donnan and colleagues 2025 | 150 mg/kg in 250 mL sugar-free squash, one hour before exercise | Against placebo, 8 soccer players | 4 |
| van de Rest and colleagues 2017 | 100, 150 or 200 mg/kg, single, in banana-flavoured yoghurt | 17 older adults, no placebo arm; 17 young adults at 150 mg/kg | 2 |
A DailyMed search for "tyrosine" listed 32 labels, such as parenteral amino acid solutions and homeopathic products; none of them was read, so no label dose for oral L-tyrosine is given here.
Side effects reported
The sources read report few adverse-event data, and several are PubMed records without full text. In the van de Rest trial, which gave single doses of 100 to 200 mg/kg, the authors write "Tyrosine administrations were well tolerated; no adverse events were reported".2 Neri and colleagues write that the results "suggest that tyrosine is a relatively benign treatment at this dose" (150 mg/kg in a split dose).9 Donnan and colleagues refer to doses of 300 mg/kg previously administered in the literature, with cognitive benefits observed and "no adverse tyrosine-related supplementation side effects" noted, without giving adverse-event data.4 The Deijen trials reported lower blood pressure after tyrosine (diastolic at 15 min in 1994; systolic in 1999), a measured effect rather than a listed adverse event.7,8
Bloodwork and markers
Regulatory and anti-doping status
Sources in this part
What is not known
Sources in this part
No elimination half-life or oral bioavailability for tyrosine was identified in the records returned by the PubMed queries run, so the app's 2.5 h and 90% have no figure from the sources beside them here. Hase and colleagues call for studies "in larger groups over multiple weeks", since nearly all of the studies they reviewed involved one test session.1 The only trial read that tested more than one dose against a plasma response in older adults had no placebo group; its older adults had lower 3-back accuracy at higher doses relative to 100 mg/kg, whereas the authors note that other studies using 150 mg/kg in young adults have shown beneficial effects on working memory.2 The records read give no head-to-head comparison of the app's 500–2000 mg range with the per-kilogram doses used in most of the trials.
Frequently asked questions
What is the half-life of L-tyrosine?
The app lists about 2.5 hours, and none of the records read gives an elimination half-life. After single doses of 100 to 200 mg/kg in older adults, plasma tyrosine was falling from 2.5 hours but had not returned to baseline within four hours.2
How long does L-tyrosine take to reach its peak level?
What is the bioavailability of L-tyrosine?
The app lists 90%, and none of the records read gives an oral bioavailability figure.
Is L-tyrosine banned by WADA?
Tyrosine is not named in the WADA Prohibited List 2026 text that was searched, which came into effect on 1 January 2026.16
What does L-tyrosine do in the body?
Hase and colleagues describe it as the precursor to the catecholamine neurotransmitters dopamine and norepinephrine.1
Does L-tyrosine improve exercise performance in trials?
Did L-tyrosine improve cognition in trials?
Results were mixed: Jongkees and colleagues concluded it enhances cognition only when neurotransmitter function is intact and dopamine or norepinephrine is temporarily depleted.3 Coull and colleagues reported no effect on cognitive function in the heat, and McAllister and colleagues reported fewer missed Stroop responses with 2000 mg but no change in stress markers.6,12
What side effects of L-tyrosine were reported in trials?
The van de Rest trial reported that tyrosine administrations were well tolerated and no adverse events were reported, after single doses of 100 to 200 mg/kg in 17 older adults.2 The Deijen trials reported lower blood pressure after tyrosine, and Waters and colleagues reported stimulated prolactin release.8,10
Guides, tools and comparisons
References
- Hase A, Jung SE, aan het Rot M. Behavioral and cognitive effects of tyrosine intake in healthy human adults. Pharmacol Biochem Behav 2015. PMID 25797188
- van de Rest O, et al. Dose-dependent effects of oral tyrosine administration on plasma tyrosine levels and cognition in aging. Nutrients 2017. PMC5748730
- Jongkees BJ, et al. Effect of tyrosine supplementation on clinical and healthy populations under stress or cognitive demands: a review. J Psychiatr Res 2015. PMID 26424423
- Donnan KJ, Williams EL, Stanger N. Tyrosine supplementation is ineffective in facilitating soccer players' physical and cognitive performance during high-intensity intermittent exercise in hot conditions. PLOS ONE 2025. PMC11737745
- Tumilty L, et al. No influence of low-, medium-, or high-dose tyrosine on exercise in a warm environment. Med Sci Sports Exerc 2020. PMID 31834099
- Coull N, et al. Tyrosine ingestion and its effects on cognitive and physical performance in the heat. Med Sci Sports Exerc 2016. PMID 26285023
- Deijen JB, Orlebeke JF. Effect of tyrosine on cognitive function and blood pressure under stress. Brain Res Bull 1994. PMID 8293316
- Deijen JB, et al. Tyrosine improves cognitive performance and reduces blood pressure in cadets after one week of a combat training course. Brain Res Bull 1999. PMID 10230711
- Neri DF, et al. The effects of tyrosine on cognitive performance during extended wakefulness. Aviat Space Environ Med 1995. PMID 7794222
- Waters WF, et al. A comparison of tyrosine against placebo, phentermine, caffeine, and D-amphetamine during sleep deprivation. Nutr Neurosci 2003. PMID 12887139
- Magill RA, et al. Effects of tyrosine, phentermine, caffeine, D-amphetamine, and placebo on cognitive and motor performance deficits during sleep deprivation. Nutr Neurosci 2003. PMID 12887140
- McAllister MJ, et al. Impact of L-theanine and L-tyrosine on markers of stress and cognitive performance in response to a virtual reality based active shooter training drill. Stress 2024. PMID 38975711
- Texas State University. Impact of Supplements on Stress Markers. ClinicalTrials.gov NCT05592561. NCT05592561
- Attipoe S, et al. Tyrosine for mitigating stress and enhancing performance in healthy adult humans, a rapid evidence assessment of the literature. Mil Med 2015. PMID 26126245
- Solon-Júnior LJF, et al. The effect of tyrosine supplementation on whole-body endurance performance in physically active population: a systematic review and meta-analysis including GRADE qualification. J Sports Sci 2023. PMID 38290812
- World Anti-Doping Agency. World Anti-Doping Code International Standard: Prohibited List 2026. WADA list